Nanomaterials for bone metastasis

X Hao, B Jiang, J Wu, D Xiang, Z Xiong, C Li… - Journal of Controlled …, 2024 - Elsevier
Bone metastasis, a prevalent occurrence in primary malignant tumors, is often associated
with a grim prognosis. The bone microenvironment comprises various coexisting cell types …

Bone-targeted biomaterials: Strategies and applications

X Ren, X Chen, Z Geng, J Su - Chemical Engineering Journal, 2022 - Elsevier
Bone diseases including osteoarthritis, osteoporosis, and bone tumors are becoming severe
threats to public health. Bone-targeted biomaterials-based strategies could improve …

[HTML][HTML] Bisphosphonate conjugation for bone specific drug targeting

KB Farrell, A Karpeisky, DH Thamm, S Zinnen - Bone reports, 2018 - Elsevier
Bones provide essential functions and are sites of unique biochemistry and specialized
cells, but can also be sites of disease. The treatment of bone disorders and neoplasia has …

Nanomedicines for the treatment of hematological malignancies

AK Deshantri, AV Moreira, V Ecker… - Journal of Controlled …, 2018 - Elsevier
Hematological malignancies (HM) are a collection of malignant transformations originating
from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …

Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration

W Gu, C Wu, J Chen, Y Xiao - International journal of …, 2013 - Taylor & Francis
Nanotechnology is a vigorous research area and one of its important applications is in
biomedical sciences. Among biomedical applications, targeted drug delivery is one of the …

Synthesis of silver nanoparticles for the dual delivery of doxorubicin and alendronate to cancer cells

F Benyettou, R Rezgui, F Ravaux, T Jaber… - Journal of Materials …, 2015 - pubs.rsc.org
We present the synthesis of a silver nanoparticle (AgNP) based drug-delivery system that
achieves the simultaneous intracellular delivery of doxorubicin (Dox) and alendronate (Ald) …

Nanoparticles and their potential for application in bone

A Tautzenberger, A Kovtun… - International journal of …, 2012 - Taylor & Francis
Biomaterials are commonly applied in regenerative therapy and tissue engineering in bone,
and have been substantially refined in recent years. Thereby, research approaches focus …

Recent advances in the treatment of bone metastases and primary bone tumors: An up-to-date review

AE Bădilă, DM Rădulescu, AG Niculescu… - Cancers, 2021 - mdpi.com
Simple Summary Bone represents a common metastatic site for patients with advanced
cancers while also being associated with rare but challenging primary tumors. As the …

Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer

SI Thamake, SL Raut, Z Gryczynski, AP Ranjan… - Biomaterials, 2012 - Elsevier
Delivery of therapeutic agents to bone is crucial in several diseases such as osteoporosis,
Paget's disease, myeloproliferative diseases, multiple myeloma as well as skeletal …

Targeting polymer therapeutics to bone

SA Low, J Kopeček - Advanced drug delivery reviews, 2012 - Elsevier
An aging population in the developing world has led to an increase in musculoskeletal
diseases such as osteoporosis and bone metastases. Left untreated many bone diseases …